Kewaunee Scientific (Kewaunee Scientific) Cash And Cash Equivalents

: $21.3 Mil (As of Jan. 2024)

View and export this data going back to 1992. Start your Free Trial

Kewaunee Scientific's quarterly cash and cash equivalents increased from Jul. 2023 ($12.70 Mil) to Oct. 2023 ($13.72 Mil) and increased from Oct. 2023 ($13.72 Mil) to Jan. 2024 ($21.31 Mil).

Kewaunee Scientific's annual cash and cash equivalents declined from Apr. 2021 ($5.21 Mil) to Apr. 2022 ($4.43 Mil) but then increased from Apr. 2022 ($4.43 Mil) to Apr. 2023 ($8.08 Mil).

Kewaunee Scientific Cash And Cash Equivalents Historical Data

The historical data trend for Kewaunee Scientific's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kewaunee Scientific Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Cash And Cash Equivalents

10.65

4.37

5.21

4.43

8.08

Kewaunee Scientific Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash And Cash Equivalents																13.05	8.08	12.70	13.72	21.31

Kewaunee Scientific Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Kewaunee Scientific (NAS:KEQU) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Kewaunee Scientific Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Kewaunee Scientific's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Kewaunee Scientific (Kewaunee Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Furnishings, Fixtures & Appliances » Kewaunee Scientific Corp (NAS:KEQU) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

KEW:Germany

Address

2700 West Front street, Statesville, NC, USA, 28677-2927

Website

https://www.kewaunee.com

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company operates through two segments: Domestic and International. The Domestic business segment designs manufacture and install scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International business segment provides facility design, engineering, construction and project management from the planning stage through the testing and commissioning of laboratories. The company generates a majority of its revenue from the Domestic business segment.

Executives

Douglas J. Batdorff	officer: VP of Manufacturing Operations	2700 WEST FRONT STREET, STATESVILLE NC 28677
Ryan S. Noble	officer: VP-Sales & Marketing-Americas	2700 WEST FRONT STREET, STATESVILLE NC 28677
Elizabeth D Phillips	officer: VP - Human Resources	2700 WEST FRONT STREET, STATESVILLE NC 28677
John Russell	director	2331 MOHAWK LANE, GLENVIEW IL 60026
Hull Thomas David Iii	director, officer: President, CEO	2700 WEST FRONT STREET, STATESVILLE NC 28677
Gardner Donald T. Iii	officer: Chief Financial Officer	2700 WEST FRONT STREET, STATESVILLE NC 28677
Keith M Gehl	director	PO BOX 1017, CHARLOTTE NC 26201-1017
David Rhind	director	1450 NORTH DEARBORN STREET, APT. 1A, CHICAGO IL 60610
Margaret B Pyle	director	2700 WEST FRONT STREET, STATESVILLE NC 28677-2927
Donald F. Shaw	director	662 EAST SUNBURST LANE, TEMPE AZ 85284-1599
Mandar Ranade	officer: VP-Information Technology	2700 WEST FRONT STREET, STATESVILLE NC 28677-2927
Michael G. Rok	officer: VP of Manufacturing Operations	2700 WEST FRONT STREET, STATESVILLE NC 28677-2927
Lisa L. Ryan	officer: VP-Construction/Cust. Servs.	2700 WEST FRONT STREET, STATESVILLE NC 28677-2927
Kurt P Rindoks	officer: VP - Engineering/Prod. Dev.	2700 WEST FRONT STREET, STATESVILLE NC 28677-2927
Bhoopathy Sathyamurthy	officer: VP-Managing Director-Int'l Ops	2700 WEST FRONT STREET, STATESVILLE NC 28677-2927